| LLY | ELI LILLY + CO | 13.57% |
| JNJ | JOHNSON + JOHNSON | 10.71% |
| ABBV | ABBVIE INC | 7.00% |
| MRK | MERCK + CO. INC. | 5.43% |
| UNH | UNITEDHEALTH GROUP INC | 5.43% |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.67% |
| AMGN | AMGEN INC | 3.56% |
| GILD | GILEAD SCIENCES INC | 3.26% |
| ABT | ABBOTT LABORATORIES | 3.15% |
| ISRG | INTUITIVE SURGICAL INC | 3.08% |
The State Street Health Care Select Sector SPDR ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index (the "Index").The Index seeks to provide an effective representation of the health care sector of the S&P 500 Index.Seeks to provide precise exposure to companies in the pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology industries.Allows investors to take strategic or tactical positions at a more targeted level than traditional style based investing.
State Street Health Care Select Sector SPDR ETF · Issued by SPDR

--(BUSINESS WIRE)--Today, Optum Rx announced a new pharmacy care model that fundamentally changes how pharmacy benefits are priced and delivered — replacing traditional approaches tied to drug prices set by manufacturers or prescription volume with a transparent, fee‑based structure offered to every Optum Rx PBM customer. The model is designed to fully align incentives with patients and plan sponsors, bringing greater clarity, predictability and affordability to pharmacy care — supported by dig.